This inventor holds 1 USPTO granted patent. Top assignee: The Translational Genomics Research Institute. Active years: 2015.
Company Filing History:
Years Active: 2015
Title: Matt Huentelman: Innovator in Alzheimer's Disease Research
Introduction
Matt Huentelman is a prominent inventor based in Phoenix, AZ, who has made significant contributions to the field of Alzheimer's disease research. His work focuses on identifying genetic markers that can predict the risk of developing late-onset Alzheimer's disease. With a strong commitment to advancing medical science, Huentelman has dedicated his career to understanding the complexities of this debilitating condition.
Latest Patents
Huentelman holds a patent related to markers associated with Alzheimer's disease. This patent discloses single nucleotide polymorphisms (SNPs) capable of predicting increased or decreased risk of developing late-onset Alzheimer's disease. His innovative approach has the potential to transform how we assess and manage the risk of this disease.
Career Highlights
Huentelman is affiliated with the Translational Genomics Research Institute, where he collaborates with other leading scientists in the field. His research has garnered attention for its potential to improve early detection and intervention strategies for Alzheimer's disease. With a focus on translating genomic discoveries into clinical applications, Huentelman is at the forefront of Alzheimer's research.
Collaborations
One of Huentelman's notable collaborators is Eric M. Reiman, a respected figure in Alzheimer's research. Together, they work on projects that aim to deepen the understanding of genetic factors influencing Alzheimer's disease. Their partnership exemplifies the collaborative spirit that drives innovation in medical research.
Conclusion
Matt Huentelman is a dedicated inventor whose work in Alzheimer's disease research is paving the way for new diagnostic tools and treatment strategies. His contributions are vital to the ongoing fight against this challenging condition.